Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31118803 | 1.00 | CXCR6 (1.00) | CXCR6CXCR4 | |
| SCHEMBL30027796 | 1.00 | CXCR6 (1.00) | CXCR6CXCR4 | |
| SCHEMBL30028515 | 0.77 | CXCR6 (1.00) | CXCR6CXCR4 | |
| SCHEMBL30028230 | 0.74 | CXCR6 (1.00) | CXCR6CXCR4 | |
| SCHEMBL3415947 | 0.73 | KMT2A (0.98) | CXCR6 | |
| SCHEMBL13856379 | 0.73 | KMT2A (0.98) | CXCR6 | |
| Hydrochloric Acid SCHEMBL2114038 | 0.72 | KMT2A (1.00) | CXCR6 | |
| SCHEMBL30027277 | 0.72 | CXCR6 (0.83) | CXCR6CXCR4 | |
| SCHEMBL22891537 | 0.70 | TSHR (0.64) | CXCR6CXCR4 | |
| SCHEMBL21928924 | 0.69 | POLB (0.59) | CXCR6CXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220402908-A1 | CXCR6 INHIBITORS AND METHODS OF USE | Sanford Burnham Prebys Medical Discovery Institute | 2022-12-22 | — | — | US | disclosed |
| WO-2021007208-A1 | CXCR6 INHIBITORS AND METHODS OF USE | Sanford Burnham Prebys Medical Discovery Institute (US) | 2021-01-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220402908-A1 | CXCR6 INHIBITORS AND METHODS OF USE | CXCR6, CXCR1, CXCR5 | CXCR6 1/4885CXCR4 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.